Low serum 25-hydroxy vitamin D levels are associated with aggressive breast cancer variants and poor prognostic factors in patients with breast carcinoma

This publication has 17 references indexed in Scilit:

• The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation
  Cancers, 2013
• Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
  Breast Cancer Research and Treatment, 2013
• The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease
  Contemporary Clinical Trials, 2012
• Vitamin D deficiency in newly diagnosed breast cancer patients
  Indian Journal of Endocrinology and Metabolism, 2012
• Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study
  Breast Cancer Research, 2011
• Estrogen Receptor Negative Breast Cancer in India: Do We Really Have Higher Burden of this Subtype?
  Indian Journal of Surgical Oncology, 2011
• Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer
  Journal of Clinical Oncology, 2009
• Vitamin D for Cancer Prevention: Global Perspective
  Annals of Epidemiology, 2009
• Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk
  Cancer Prevention Research, 2009
• Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1996